What antibiotic regimen is recommended for a female patient with a urinary tract infection caused by Enterococcus faecalis, with normal renal function and no known antibiotic allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Enterococcus faecalis Wound Infection

Direct Recommendation

For this female patient with a wound infection (not urinary tract infection despite the "urine culture" label appearing to be a documentation error given the "Source: Wound" notation) caused by ampicillin-susceptible Enterococcus faecalis, prescribe ampicillin 2 grams IV every 6 hours for 7-14 days depending on clinical response and source control. 1

Rationale Based on Susceptibility Profile

Your culture shows the organism is susceptible to multiple agents with the following MICs:

  • Ampicillin: ≤2 (Susceptible) - This is your first-line choice 1
  • Penicillin: 8 (Susceptible)
  • Vancomycin: 1 (Susceptible)
  • Linezolid: 2 (Susceptible)
  • Tigecycline: ≤0.12 (Susceptible)

Treatment Algorithm

First-Line Therapy (Recommended)

  • Ampicillin 2 grams IV every 6 hours is the drug of choice for ampicillin-susceptible E. faecalis infections 1
  • Duration: 7-14 days for soft tissue/wound infections depending on clinical improvement 1
  • This can be transitioned to oral amoxicillin 500 mg three times daily once clinical improvement is documented and the patient can tolerate oral intake 1

Alternative Options (If Ampicillin Contraindicated)

If penicillin allergy:

  • Vancomycin 15-20 mg/kg IV every 12 hours (target trough 10-15 mcg/mL) 2
  • Duration: Same as ampicillin regimen

If concerns about IV access or transition to outpatient therapy:

  • Linezolid 600 mg IV or PO every 12 hours 2, 3
  • Advantage: Excellent oral bioavailability, no renal adjustment needed
  • Critical monitoring requirement: Weekly complete blood counts due to risk of thrombocytopenia, anemia, and peripheral neuropathy with prolonged use 3

Important Clinical Considerations

Why NOT Other Agents

Gentamicin synergy is NOT needed for wound infections:

  • The culture shows "Gentamicin High Level (Synergy): S, SYN-S" - this synergy testing is relevant only for endocarditis, not soft tissue infections 2
  • Aminoglycosides should be avoided in routine wound infections due to nephrotoxicity risk without added benefit 2

Tigecycline should be avoided:

  • Despite excellent susceptibility (MIC ≤0.12), tigecycline achieves low serum levels and should not be used for bacteremia or serious infections outside the abdomen 2
  • Reserved for intra-abdominal infections involving VRE 2

Source Control is Critical

Failure to achieve adequate source control will lead to treatment failure regardless of antibiotic choice 3:

  • Debride necrotic tissue if present
  • Remove foreign bodies if applicable
  • Drain any abscesses
  • Consider wound care consultation for complex wounds

Common Pitfalls to Avoid

Do not underdose ampicillin:

  • The full 2 grams every 6 hours (8 grams daily) is necessary for adequate tissue penetration in serious infections 1
  • Lower doses may be appropriate only for uncomplicated urinary tract infections where high urinary concentrations are achieved 2

Do not assume this is a UTI:

  • Despite the "urine culture" header, the specimen source is clearly documented as "WOUND" [@culture report]
  • UTI treatment algorithms (nitrofurantoin, fosfomycin) do not apply here [@2@, 2, @13@]

Do not use cephalosporins:

  • Enterococci have intrinsic resistance to cephalosporins despite what automated susceptibility systems may suggest [2, @5@]

Do not use fluoroquinolones:

  • E. faecalis has high rates of fluoroquinolone resistance (46-58% in recent studies), making ciprofloxacin unreliable even if reported susceptible [@11@]

Monitoring During Therapy

  • Clinical response: Improvement in wound appearance, decreased purulence, resolution of fever/leukocytosis within 48-72 hours
  • If no improvement by 72 hours: Re-evaluate for source control issues, consider imaging for deeper infection, repeat cultures
  • Transition to oral therapy: Once afebrile for 24-48 hours with clinical improvement, switch to amoxicillin 500 mg PO three times daily to complete course [@

References

Guideline

Oral Amoxicillin Dosing for Susceptible Enterococcus faecalis Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Enterococcus faecalis Bacteremia in Patients with Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.